Lunai Bioworks Inc.: amortization of intangible assets

What this measure means

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Exact concept: us-gaap:AmortizationOfIntangibleAssets. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2016-07-01 to 2025-06-30. The SEC response was captured on 2026-09-19.

Selected filing history

Related financial histories

• Lunai Bioworks Inc.: total assets
• Lunai Bioworks Inc.: total liabilities
• Lunai Bioworks Inc.: stockholders equity
• Lunai Bioworks Inc.: cash and cash equivalents
• Lunai Bioworks Inc.: net income or loss
• Lunai Bioworks Inc.: operating cash flow
• Lunai Bioworks Inc.: capital expenditure payments
• Lunai Bioworks Inc.: financing cash flow
• Lunai Bioworks Inc.: investing cash flow
• Lunai Bioworks Inc.: retained earnings or deficit
• Lunai Bioworks Inc.: basic weighted-average shares
• Lunai Bioworks Inc.: diluted weighted-average shares
• Lunai Bioworks Inc.: basic earnings per share
• Lunai Bioworks Inc.: diluted earnings per share
• Lunai Bioworks Inc.: income tax expense or benefit
• Lunai Bioworks Inc.: net property, plant and equipment
• Lunai Bioworks Inc.: share-based compensation expense
• Lunai Bioworks Inc.: operating income or loss
• Lunai Bioworks Inc.: current assets
• Lunai Bioworks Inc.: interest expense
• Lunai Bioworks Inc.: current liabilities
• Lunai Bioworks Inc.: goodwill carrying amount
• Lunai Bioworks Inc.: net finite-lived intangible assets
• Lunai Bioworks Inc.: operating expenses
• Lunai Bioworks Inc.: gross profit
• Lunai Bioworks Inc.: research and development expense
• Lunai Bioworks Inc.: common shares outstanding
• Lunai Bioworks Inc.: cash including restricted cash
• Lunai Bioworks Inc.: additional paid-in capital
• Lunai Bioworks Inc.: accumulated other comprehensive income or loss
• Lunai Bioworks Inc.: operating lease right-of-use asset
• Lunai Bioworks Inc.: long-term debt
• Lunai Bioworks Inc.: gross property, plant and equipment
• Lunai Bioworks Inc.: accumulated depreciation on property, plant and equipment
• Lunai Bioworks Inc.: other noncurrent assets
• Lunai Bioworks Inc.: other noncurrent liabilities
• Lunai Bioworks Inc.: accrued current liabilities
• Lunai Bioworks Inc.: pre-tax income or loss from continuing operations
• Lunai Bioworks Inc.: profit or loss including noncontrolling interests
• Lunai Bioworks Inc.: comprehensive income or loss
• Lunai Bioworks Inc.: general and administrative expense
• Lunai Bioworks Inc.: depreciation expense
• Lunai Bioworks Inc.: depreciation, depletion and amortization
• Lunai Bioworks Inc.: nonoperating interest expense
• Lunai Bioworks Inc.: nonoperating income or expense
• Lunai Bioworks Inc.: current income tax expense or benefit
• Lunai Bioworks Inc.: deferred income tax expense or benefit
• Lunai Bioworks Inc.: interest paid, net
• Lunai Bioworks Inc.: income taxes paid, net
• Lunai Bioworks Inc.: proceeds from issuing common stock
• Lunai Bioworks Inc.: change in accounts receivable
• Lunai Bioworks Inc.: change in accounts payable

Inspect the source

Entity

Lunai Bioworks Inc. / CIK 0001527728

Captured

2026-09-19T11:18:43.497Z

SEC response SHA-256

ac98dc0ce9d3f6a81ccca9ca1f946e5772f94eabe3529dac2d726fef17abed57

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001527728.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))